Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin

R Coria-Jiménez1, C Ortiz-Torres

  • 1Laboratorio de Bacteriología, Instituto Nacional de Pediatría, Delegación Coyoacan, México, D.F.

Insights

Aminoglycoside resistance in Serratia marcescens clinical strains varied by institution and time. A significant increase in aminoglycoside-resistant strains was observed, suggesting selection pressures.

Area of Science:

  • Microbiology
  • Antimicrobial Resistance
  • Clinical Bacteriology

Background:

  • Serratia marcescens is an opportunistic pathogen.
  • Aminoglycosides are crucial antibiotics for treating Gram-negative infections.
  • Monitoring antimicrobial resistance patterns is vital for effective treatment strategies.

Purpose of the Study:

  • To investigate the aminoglycoside resistance patterns of clinical Serratia marcescens isolates.
  • To identify variations in resistance based on isolation time and location.
  • To assess the prevalence of aminoglycoside resistance over a 12-year period.

Main Methods:

  • Analysis of 147 clinical Serratia marcescens strains.
  • Characterization of bacterial populations and resistance profiles.
  • Correlation of resistance patterns with study periods and isolation institutions.

Main Results:

  • Significant correlations found between resistance patterns, study periods, and institutions.
  • Predominant resistance patterns included ACC(6')-I and ANT(2'') + AAC(6')-I.
  • A marked decrease in aminoglycoside-sensitive strains was observed at the National Institute of Pediatrics over 12 years.

Conclusions:

  • Institutional and temporal factors influence Serratia marcescens aminoglycoside resistance.
  • Evidence suggests selection for highly aminoglycoside-resistant Serratia marcescens strains.
  • Ongoing surveillance is necessary to track evolving resistance trends.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...